Page last updated: 2024-08-23

etoposide and Immune Reconstitution Disease

etoposide has been researched along with Immune Reconstitution Disease in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Borok, M; Campbell, TB; Caruso, S; Dittmer, DP; Godfrey, C; Hoagland, B; Hosseinipour, MC; Kang, M; Krown, SE; Martinez-Maza, O; Mngqibisa, R; Mwelase, N; Ngongondo, M; Nyirenda, M; Samaneka, W; Umbleja, T	1
Ambinder, R; Borok, M; Bukuru, A; Busakhala, N; Campbell, TB; Dittmer, DP; Godfrey, C; Hoagland, B; Hosseinipour, MC; Kang, M; Krown, SE; Langat, D; MacRae, J; Martin, JN; Martínez-Maza, O; Mngqbisa, R; Moses, A; Mwelase, N; Nokta, M; Nyirenda, M; Orem, J; Samaneka, W; Umbleja, T	1

Trials

2 trial(s) available for etoposide and Immune Reconstitution Disease

Article	Year
Early Progression and Immune Reconstitution Inflammatory Syndrome During Treatment of Mild-To-Moderate Kaposi Sarcoma in Sub-Saharan Africa and South America: Incidence, Long-Term Outcomes, and Effects of Early Chemotherapy. Journal of acquired immune deficiency syndromes (1999), 2020, 08-01, Volume: 84, Issue:4 Topics: Adult; Africa South of the Sahara; Anti-HIV Agents; Antineoplastic Agents, Phytogenic; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Disease Progression; Etoposide; Female; HIV Infections; Humans; Immune Reconstitution Inflammatory Syndrome; Male; Sarcoma, Kaposi; South America; Treatment Outcome	2020
As-Needed Vs Immediate Etoposide Chemotherapy in Combination With Antiretroviral Therapy for Mild-to-Moderate AIDS-Associated Kaposi Sarcoma in Resource-Limited Settings: A5264/AMC-067 Randomized Clinical Trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2018, 07-02, Volume: 67, Issue:2 Topics: Administration, Oral; Adult; Africa South of the Sahara; AIDS-Related Opportunistic Infections; Antineoplastic Agents, Phytogenic; Antiretroviral Therapy, Highly Active; Biopsy; Etoposide; Female; Health Resources; HIV Infections; Humans; Immune Reconstitution Inflammatory Syndrome; Male; Sarcoma, Kaposi; Skin; South America	2018

Article

Year

Early Progression and Immune Reconstitution Inflammatory Syndrome During Treatment of Mild-To-Moderate Kaposi Sarcoma in Sub-Saharan Africa and South America: Incidence, Long-Term Outcomes, and Effects of Early Chemotherapy.

Journal of acquired immune deficiency syndromes (1999), 2020, 08-01, Volume: 84, Issue:4

Topics: Adult; Africa South of the Sahara; Anti-HIV Agents; Antineoplastic Agents, Phytogenic; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Disease Progression; Etoposide; Female; HIV Infections; Humans; Immune Reconstitution Inflammatory Syndrome; Male; Sarcoma, Kaposi; South America; Treatment Outcome

2020

As-Needed Vs Immediate Etoposide Chemotherapy in Combination With Antiretroviral Therapy for Mild-to-Moderate AIDS-Associated Kaposi Sarcoma in Resource-Limited Settings: A5264/AMC-067 Randomized Clinical Trial.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2018, 07-02, Volume: 67, Issue:2

Topics: Administration, Oral; Adult; Africa South of the Sahara; AIDS-Related Opportunistic Infections; Antineoplastic Agents, Phytogenic; Antiretroviral Therapy, Highly Active; Biopsy; Etoposide; Female; Health Resources; HIV Infections; Humans; Immune Reconstitution Inflammatory Syndrome; Male; Sarcoma, Kaposi; Skin; South America

2018